Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:

Pharmacia Farms Out CEOs: Rothwell To Head Sanofi North America

  • News

Executive Summary

Sanofi-Synthelabo North America CEO-designate Tim Rothwell will bring extensive experience in the low-molecular weight heparin category to help re-energize the launch of Arixtra

You may also be interested in...



Sanofi-Aventis Begins Operations; Markham, Senior Aventis Execs Depart

Sanofi-Aventis is beginning operations as a top 10 pharmaceutical company in the U.S

Sanofi-Aventis Begins Operations; Markham, Senior Aventis Execs Depart

Sanofi-Aventis is beginning operations as a top 10 pharmaceutical company in the U.S

Sanofi-Aventis Picks Two U.S. Heads: Rothwell, Soriot On Management Cmte.

Sanofi-Aventis' U.S. business will be overseen by Sanofi U.S. CEO Tim Rothwell and Aventis U.S. Pharmaceutical Operations Head Pascal Soriot under a draft structure of the company's management team

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Tags:
UsernamePublicRestriction

Register

ID1132542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By